Quandries of Responsible Innovation: The Case of Alzheimer's Disease

Yvonne Cuijpers, Harro van Lente, M. Boenink, Ellen Moors

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademic

Abstract

The interest in responsible innovation has led to various activities to
include social, economic and moral concerns in the process of innovation. This
ambition, however, brings along several fundamental questions. We encountered
these in a project on responsible innovation in the case of new molecular early diagnostics
for Alzheimer’s disease (AD). Currently, a number of novel technologies are
being developed for in vivo early diagnosis of AD, by identifying and testing new
molecular biomarkers. In our project, we study scientific and clinical uncertainties
in technology development, analyze the social and cultural as well as the moral
implications of existing and alternative ways to deal with them. In this chapter we
summarize the fundamental questions about responsible innovation in terms of six
‘quandaries’: problematic, difficult and ambiguous conditions that somehow require
fundamental and practical decisions.
Original languageEnglish
Title of host publicationResponsible Innovation
Subtitle of host publicationVolume 1: Innovative Solutions for Global Issues
EditorsJeroen van den Hoven, Neelke Doorn, Tsjalling Swierstra, Bert-Jaap Koops, Henny Romijn
Place of PublicationDordrecht
PublisherSpringer
Pages239-254
Number of pages16
ISBN (Electronic)978-94-017-8956-1
Publication statusPublished - 2014

Fingerprint

Dive into the research topics of 'Quandries of Responsible Innovation: The Case of Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this